Delivery Order SPE2DR25D7068-SPE2DR26F5BR4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,745.98 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 10, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,484.65 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed-price, competitive award with no set-aside designation, with an ultimate completion date of November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,936.60 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in 10-gram units, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct procurement through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.66 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% foam in a 10-gram formulation. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency has awarded a delivery order valued at $1,362.40 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. The contract, valued at $2,449.26, was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, and was competitively awarded without a set-aside designation. This delivery order represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,642.36 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025, and represents a firm fixed-price, non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitive, non-set-aside award utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.58 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam, a topical pharmaceutical product in a 10-gram formulation. This non-competitive delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BR4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,899.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, one day after the award date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The order will be fulfilled from the company's Conshohocken location. This delivery order represents a small transaction within AmerisourceBergen's broader federal contract portfolio with the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026, which serves as the parent vehicle enabling the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's contract awards with the DLA demonstrate its established capability to meet federal procurement requirements through open competition, delivering diverse medical commodities including specialty medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 11/23/25 |